Related Experiment Video
Updated: Feb 9, 2026

Author Spotlight: Enhancing Understanding and Treatment Strategies with the NEC-on-a-Chip Model
Published on: July 28, 2023
Topiramate for Seizures in Preterm Infants and the Development of Necrotizing Enterocolitis
Benjamin Courchia1, Waleed Kurtom2, Alyssa Pensirikul3
1Divisions of Neonatology and benjamin.courchia@jhsmiami.org.
Insights
Topiramate is increasingly used for neonatal seizures, but a case series suggests a link to necrotizing enterocolitis in preterm infants. Further research is needed to understand this potential risk.
Area of Science:
- Neonatal Neurology
- Pediatric Pharmacology
- Gastroenterology
Background:
- Neonatal seizures pose significant neurodevelopmental risks.
- No FDA-approved antiepileptic drugs exist for neonates, leading to off-label use.
- Topiramate is a commonly used third-line treatment for neonatal seizures.
Observation:
- This study reports on 4 preterm neonates treated with oral topiramate for seizures between 2015 and 2017.
- All neonates developed clinical and radiographic signs of necrotizing enterocolitis after topiramate administration.
Findings:
- Necrotizing enterocolitis presented with abdominal distention, hemoccult-positive stools, and intestinal pneumatosis.
- The findings suggest a potential association between topiramate use and necrotizing enterocolitis in preterm infants.
Implications:
- The findings highlight a potential adverse event associated with topiramate in a vulnerable neonatal population.
- Further research is crucial to investigate risk factors and establish causality.
- This underscores the need for careful monitoring and consideration of alternative treatments.
Abstract:
Neonatal seizures represent a significant health burden on the term and preterm neonatal population and are linked to poor long-term neurodevelopmental outcomes. Currently, there are no US Food and Drug Administration-approved antiepileptic drugs for neonates, and authors of the medical literature have yet to reach a consensus on the most adequate approach to neonatal seizures. Topiramate is readily used in the adult and older pediatric population for the management of migraines and partial-onset seizures. Topiramate continues to gain favor among pediatric neurologists who often recommend this medication as a third-line treatment of neonatal seizures. We report our recent experience with 4 preterm neonates, born between 2015 and 2017, who developed radiographic signs of necrotizing enterocolitis after receiving topiramate for seizures. Each was given oral topiramate for the treatment of electrographic and clinical seizures and developed the subsequent diagnosis of necrotizing enterocolitis, with abdominal distention, hemoccult-positive stools, and radiographic signs of intestinal distention and pneumatosis. More research regarding the risk factors of topiramate use in premature infants is needed.
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Drug Dosing: Infants and Children
Sustainable Development
Development of the Lymphatic System
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
Language Development
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...

